T. Rosén

3.4k total citations · 1 hit paper
19 papers, 2.8k citations indexed

About

T. Rosén is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, T. Rosén has authored 19 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in T. Rosén's work include Growth Hormone and Insulin-like Growth Factors (17 papers), Lipid metabolism and disorders (6 papers) and Sexual Differentiation and Disorders (6 papers). T. Rosén is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (17 papers), Lipid metabolism and disorders (6 papers) and Sexual Differentiation and Disorders (6 papers). T. Rosén collaborates with scholars based in Sweden, Italy and United Kingdom. T. Rosén's co-authors include B.‐Å. Bengtsson, Gudmundur Johannsson, Kerstin Landin‐Wilhelmsen, Lars Wilhelmsen, Georg Lappas, B-Å Bengtsson, Lars Sjöström, Ingvar Bosæus, Anders Odén and Johan Svensson and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and European Journal of Endocrinology.

In The Last Decade

T. Rosén

19 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Premature mortality due to cardiovascular disease in hypopituitarism

1990 1.1k citations T. Rosén, B.‐Å. Bengtsson The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. Rosén Sweden	14	2.5k	744	642	552	408	19	2.8k
B.‐Å. Bengtsson Sweden	22	2.6k 1.0×	797 1.1×	823 1.3×	603 1.1×	422 1.0×	42	3.4k
C Lassarre France	22	1.6k 0.6×	219 0.3×	130 0.2×	786 1.4×	360 0.9×	33	2.0k
JP Monson United Kingdom	26	1.5k 0.6×	149 0.2×	337 0.5×	398 0.7×	235 0.6×	57	2.7k
Ivo Quack Germany	22	628 0.2×	331 0.4×	220 0.3×	593 1.1×	204 0.5×	56	1.9k
Guilhèrme Pòvoa Sweden	13	998 0.4×	169 0.2×	116 0.2×	537 1.0×	193 0.5×	17	1.2k
B. Klinger Israel	23	1.3k 0.5×	237 0.3×	163 0.3×	521 0.9×	467 1.1×	43	1.5k
Giovanni Lupoli Italy	29	1.6k 0.6×	185 0.2×	96 0.1×	532 1.0×	266 0.7×	92	2.5k
M O Savage United Kingdom	23	1.2k 0.5×	249 0.3×	90 0.1×	501 0.9×	557 1.4×	67	1.7k
G. Plewe Germany	14	1.1k 0.4×	82 0.1×	223 0.3×	350 0.6×	288 0.7×	19	1.6k
J.M.P. Holly United Kingdom	21	785 0.3×	116 0.2×	103 0.2×	395 0.7×	201 0.5×	33	1.2k

Countries citing papers authored by T. Rosén

Since Specialization

Citations

This map shows the geographic impact of T. Rosén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Rosén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Rosén more than expected).

Fields of papers citing papers by T. Rosén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Rosén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Rosén. The network helps show where T. Rosén may publish in the future.

Co-authorship network of co-authors of T. Rosén

This figure shows the co-authorship network connecting the top 25 collaborators of T. Rosén. A scholar is included among the top collaborators of T. Rosén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Rosén. T. Rosén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Powrie, Jake, E. Eryl Bassett, T. Rosén, et al.. (2007). Detection of growth hormone abuse in sport. Growth Hormone & IGF Research. 17(3). 220–226. 122 indexed citations

Svensson, Johan, B.‐Å. Bengtsson, T. Rosén, Anders Odén, & Gudmundur Johannsson. (2004). Malignant Disease and Cardiovascular Morbidity in Hypopituitary Adults with or without Growth Hormone Replacement Therapy. The Journal of Clinical Endocrinology & Metabolism. 89(7). 3306–3312. 196 indexed citations

Ehrnborg, Christer, Kai Henrik Wiborg Lange, Rolf Dall, et al.. (2003). The Growth Hormone/Insulin-Like Growth Factor-I Axis Hormones and Bone Markers in Elite Athletes in Response to a Maximum Exercise Test. The Journal of Clinical Endocrinology & Metabolism. 88(1). 394–401. 93 indexed citations

Dall, Rolf, S. Longobardi, Christer Ehrnborg, et al.. (2000). The Effect of Four Weeks of Supraphysiological Growth Hormone Administration on the Insulin-Like Growth Factor Axis in Women and Men¹. The Journal of Clinical Endocrinology & Metabolism. 85(11). 4193–4200. 96 indexed citations

Longobardi, S., Nicola Keay, Christer Ehrnborg, et al.. (2000). Growth Hormone (GH) Effects on Bone and Collagen Turnover in Healthy Adults and Its Potential as a Marker of GH Abuse in Sports: A Double Blind, Placebo-Controlled Study¹. The Journal of Clinical Endocrinology & Metabolism. 85(4). 1505–1512. 123 indexed citations

Baxter, Robert C., T. Rosén, B-Å Bengtsson, et al.. (1998). Detection of growth hormone abuse in athletes. Growth Hormone & IGF Research. 8(4). 347–348. 5 indexed citations

Johannsson, Gudmundur, T. Rosén, & B.‐Å. Bengtsson. (1998). Four years of growth hormone replacement in adults with growth hormone deficiency: further increase in bone mineral density. Growth Hormone & IGF Research. 8. 194–194. 3 indexed citations

Rosén, T., B-Å Bengtsson, Rolf Dall, et al.. (1998). Bone markers and growth hormone (GH) abuse in athletes. Growth Hormone & IGF Research. 8(4). 348–348. 3 indexed citations

Wallace, Joanne, et al.. (1998). Endocrine markers of growth hormone abuse in sport. Queensland's institutional digital repository (The University of Queensland). 52–52. 1 indexed citations

10.

Rosén, T., Lars Wilhelmsen, Kerstin Landin‐Wilhelmsen, Georg Lappas, & B-Å Bengtsson. (1997). Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. European Journal of Endocrinology. 137(3). 240–245. 231 indexed citations

11.

Johannsson, Gudmundur, Ragnar Bjarnason, Margareta Bramnert, et al.. (1996). The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.. The Journal of Clinical Endocrinology & Metabolism. 81(4). 1575–1581. 154 indexed citations

12.

Johannsson, Gudmundur, T. Rosén, Ingvar Bosæus, Lars Sjöström, & B.‐Å. Bengtsson. (1996). Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.. The Journal of Clinical Endocrinology & Metabolism. 81(8). 2865–2873. 208 indexed citations

13.

Landin‐Wilhelmsen, Kerstin, Lars Wilhelmsen, Jan Wilske, et al.. (1995). Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Göteborg, Sweden (The WHO MONICA Project).. PubMed. 49(6). 400–7. 52 indexed citations

14.

Johannsson, Gudmundur, et al.. (1994). Effects of recombinant human growth hormone on adipose tissue in adults with growth hormone deficiency. Acta Paediatrica. 83(s406). 60–63. 7 indexed citations

15.

Rosén, T., et al.. (1994). Consequences of growth hormone deficiency in adults, and effects of growth hormone replacement therapy. Acta Paediatrica. 83(s399). 21–24. 19 indexed citations

16.

Landin‐Wilhelmsen, Kerstin, et al.. (1994). High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(3). 434–437. 142 indexed citations

17.

Edén, S, O. Wiklund, Jan Oscarsson, T. Rosén, & B.‐Å. Bengtsson. (1993). Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(2). 296–301. 179 indexed citations

18.

Brummer, Robert J., T. Rosén, & B.‐Å. Bengtsson. (1993). Evaluation of different methods of determining body composition, with special reference to growth hormone-related disorders.. PubMed. 128 Suppl 2. 30–6. 17 indexed citations

19.

Rosén, T. & B.‐Å. Bengtsson. (1990). Premature mortality due to cardiovascular disease in hypopituitarism. The Lancet. 336(8710). 285–288. 1143 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact